Cargando…
Dextramabs: A Novel Format of Antibody‐Drug Conjugates Featuring a Multivalent Polysaccharide Scaffold
Antibody‐drug conjugates (ADCs) are multicomponent biomolecules that have emerged as a powerful tool for targeted tumor therapy. Combining specific binding of an immunoglobulin with toxic properties of a payload, they however often suffer from poor hydrophilicity when loaded with a high amount of to...
Autores principales: | Schneider, Hendrik, Deweid, Lukas, Pirzer, Thomas, Yanakieva, Desislava, Englert, Simon, Becker, Bastian, Avrutina, Olga, Kolmar, Harald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437811/ https://www.ncbi.nlm.nih.gov/pubmed/30976476 http://dx.doi.org/10.1002/open.201900066 |
Ejemplares similares
-
Chemical Synthesis, Backbone Cyclization and Oxidative Folding of Cystine-knot Peptides — Promising Scaffolds for Applications in Drug Design
por: Reinwarth, Michael, et al.
Publicado: (2012) -
Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation In Vitro
por: Schneider, Hendrik, et al.
Publicado: (2021) -
Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic binders
por: Könning, Doreen, et al.
Publicado: (2017) -
FACS-Based Functional Protein Screening via Microfluidic Co-encapsulation of Yeast Secretor and Mammalian Reporter Cells
por: Yanakieva, Desislava, et al.
Publicado: (2020) -
Tag-free, specific conjugation of glycosylated IgG1 antibodies using microbial transglutaminase
por: Hadjabdelhafid-Parisien, Adem, et al.
Publicado: (2022)